One of the most logical drug treatments for lung cancer is arguably direct inhalation-based delivery to the lung. However, this strategy has not progressed in clinical trials despite significant investments and efforts in this area. Understanding and developing novel drug delivery strategies are made easier with the help of imaging drug delivery. In this survey we center on imaging investigations of medication conveyance by the inward breath course, to give an expansive outline of the field to date and endeavor to more readily comprehend the intricacies of this course of organization and the critical boundaries that it faces, as well as its benefits. We begin by discussing the particular difficulties associated with inhalation-based drug delivery to the lung. We focus on the obstacles that have stymied this approach's progress in oncology and the most recent developments in this field. This is trailed by an exhaustive outline of the different imaging modalities that are pertinent to lung drug conveyance, including atomic imaging, X-beam imaging, attractive reverberation imaging, optical imaging and mass spectrometry imaging.
Share this article